Exploitation of nuclear protein SFPQ by the encephalomyocarditis virus to facilitate its replication

Biochem Biophys Res Commun. 2019 Feb 26;510(1):65-71. doi: 10.1016/j.bbrc.2019.01.032. Epub 2019 Jan 18.

Abstract

The encephalomyocarditis virus (EMCV) is a single-stranded RNA virus that induces sudden death, diabetes, myocarditis and nervous disorders in non-human primates. The rapid development of xenografts such as heart transplantation from pig to human raises the issue of EMCV safety in human cells. SFPQ, a proline and glutamine rich splicing factor that participates in diverse molecular functions including paraspeckle formation, microRNA synthesis and transcription regulation, is known to regulate host innate immune response to viruses. However, the role of SFPQ in EMCV infection remains unclear. Here we reported that the SFPQ was essential for EMCV replication. Depletion of SFPQ impaired EMCV production, while forced expression of SFPQ promoted viral replication. Mechanistically, loss of SFPQ affected the transcription profile of host mitochondria pathway related genes. In addition, cellular SFPQ was exploited by EMCV and accumulated in cytoplasm and it interacted with eukaryotic initiation factors and ribosomal proteins to facilitate internal ribosome entry site (IRES)-dependent translation of EMCV protein. Altogether, our work discovered host SFPQ as a new target to inhibit EMCV replication and infection.

Keywords: EMCV; SFPQ; Translation; Translocation; Viral replication.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiovirus Infections
  • Encephalomyocarditis virus / physiology*
  • Humans
  • Internal Ribosome Entry Sites
  • PTB-Associated Splicing Factor / metabolism*
  • PTB-Associated Splicing Factor / physiology
  • Viral Proteins / biosynthesis
  • Virus Replication*

Substances

  • Internal Ribosome Entry Sites
  • PTB-Associated Splicing Factor
  • Viral Proteins